University of Arizona
OrganisationROR
People
Chair and professor14 Aug 2026reporter.nih.gov
Associate research professor14 Aug 2026reporter.nih.gov
14 Aug 2026reporter.nih.gov
20 Jul 2026reporter.nih.gov
Professor20 Jul 2026reporter.nih.gov
Professor16 Jul 2026reporter.nih.gov
Professor16 Jul 2026reporter.nih.gov
Prof and head, dept. of immunobiology15 Jul 2026reporter.nih.gov
Professor15 Jul 2026reporter.nih.gov
Regents' professor7 Jul 2026reporter.nih.gov
Associate professor7 Jul 2026reporter.nih.gov
Professor1 Jul 2026reporter.nih.gov
Assistant professor1 Jul 2026reporter.nih.gov
Associate professor16 Jun 2026reporter.nih.gov
Assistant professor15 Jun 2026reporter.nih.gov
9 Jun 2026reporter.nih.gov
Assistant professor9 Jun 2026reporter.nih.gov
Professor4 Jun 2026reporter.nih.gov
Professor of physiology1 Jun 2026reporter.nih.gov
1 Jun 2026reporter.nih.gov
Trials
Early phase 1Not yet recruiting202630 people30 Jul 2026clinicaltrials.gov
Phase 3Recruiting2026218 people17 Jul 2026clinicaltrials.gov
Early phase 1Recruiting202630 people4 Jun 2026clinicaltrials.gov
Phase 1/2Active, not recruiting2024100 people1 Aug 2025clinicaltrials.gov
Improving Mobility After Revascularization in Peripheral Artery Disease
CollaboratorPhase 3Recruiting2025386 people13 Nov 2024clinicaltrials.gov
CollaboratorPhase 1Terminated20256 people11 Oct 2023clinicaltrials.gov
Phase 2Active, not recruiting202334 people14 Feb 2022clinicaltrials.gov
CollaboratorPhase 2Completed2020701 people18 Aug 2020clinicaltrials.gov
CollaboratorPhase 2/3Completed2019350 people10 Mar 2020clinicaltrials.gov
Early phase 1Completed201950 people26 Feb 2019clinicaltrials.gov
Early phase 1Terminated20182 people6 Jul 2018clinicaltrials.gov
Phase 2Completed2003154 people25 Mar 2016clinicaltrials.gov
Phase 2Terminated201479 people7 Apr 2015clinicaltrials.gov
Phase 2Completed2014151 people7 Jan 2014clinicaltrials.gov
Phase 2Completed201314 people15 Aug 2013clinicaltrials.gov
CollaboratorPhase 1Completed201213 people4 Oct 2012clinicaltrials.gov
Phase 3Completed2001700 people17 Sept 2009clinicaltrials.gov
Phase 2Completed2002220 people15 Sept 2008clinicaltrials.gov
Phase 2Completed200628 people12 Aug 2008clinicaltrials.gov
Phase 1Completed200810 people19 Jun 2008clinicaltrials.gov
Grants and prizes
National Center for Chronic Disease Prev and Health Promo
Community-Based Participatory Research to Enhance Vaccine Uptake Across the Lifespan through Innovative Points of Access and Altering Norms in Border and Rural RegionsU48DP006882US$389.7k14 Aug 2026reporter.nih.gov
National Institute of Allergy and Infectious Diseases
R01Integrating novel cellular and molecular technologies to advance deep profiling of T cellsR01AI199138US$3.2m2026–203020 Jul 2026reporter.nih.gov
U01PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: an FDA required Toxicology StudyU01AG082617US$134.1k2023–202716 Jul 2026reporter.nih.gov
T32Infection and Inflammation as Drivers of Aging (IIDA) Predoctoral Training ProgramT32AG058503US$287.7k2019–202915 Jul 2026reporter.nih.gov
T32Postdoctoral Training, Neurobiology of Aging and Alzheimer's DiseaseT32AG044402US$12016–20277 Jul 2026reporter.nih.gov
R01Evaluation of Interaction and Time Course of Small and Large Vessel Cerebrovascular Contributions to Alzheimer's Disease RiskR01AG094088US$996.2k2026–20317 Jul 2026reporter.nih.gov
U01Nonlipogenic ABCA1 inducers for ADRDU01AG076450US$741.5k2022–20271 Jul 2026reporter.nih.gov
National Heart, Lung, and Blood Institute
K01Corazon en tus Manos: A Culturally-Tailored Stress-Reduction Intervention to Reduce Cardiovascular Disease Risk among Mexican-origin Adults with Confirmed NAFLDK01HL180816US$140.4k2026–20311 Jul 2026reporter.nih.gov
National Institute of Child Health and Human Development
R01Infertility and Long-Term Health Outcomes Among Hispanic Women with Mexican HeritageR01HD114871US$436.8k2024–202916 Jun 2026reporter.nih.gov
National Institute of Allergy and Infectious Diseases
R01CC16 in childhood and resilience to early airflow limitation in adult lifeR01AI135108US$56.2k2017–203015 Jun 2026reporter.nih.gov
National Institute of Allergy and Infectious Diseases
R01CC16 in childhood and resilience to early airflow limitation in adult lifeR01AI135108US$4.6k2017–203014 Jun 2026reporter.nih.gov
National Institute of Allergy and Infectious Diseases
R01CC16 in childhood and resilience to early airflow limitation in adult lifeR01AI135108US$8.9k2017–203013 Jun 2026reporter.nih.gov
National Institute of Allergy and Infectious Diseases
R01CC16 in childhood and resilience to early airflow limitation in adult lifeR01AI135108US$9.1k2017–203012 Jun 2026reporter.nih.gov
National Institute of Allergy and Infectious Diseases
R01CC16 in childhood and resilience to early airflow limitation in adult lifeR01AI135108US$10.8k2017–203011 Jun 2026reporter.nih.gov
R01Frontal and Temporal Lobe Interactions in Rat Models of Normative Aging and Alzheimer's DiseaseR01AG081767US$729.3k2023–20289 Jun 2026reporter.nih.gov
R01The role of CMV in HIV-associated accentuated agingR01AG082541US$1.3m2023–20289 Jun 2026reporter.nih.gov
R01Genetically Informed Studies of Social Connectedness and HealthR01AG078361US$1.2m2022–20279 Jun 2026reporter.nih.gov
National Institute of Allergy and Infectious Diseases
R03Immune evasive mouse models for transplantation researchR03AI196408US$155.5k2026–20284 Jun 2026reporter.nih.gov
National Institute of Allergy and Infectious Diseases
R01CC16 in childhood and resilience to early airflow limitation in adult lifeR01AI135108US$664.7k2017–20302 Jun 2026reporter.nih.gov
National Center for Complementary and Integrative Health (NCCIH)
R01A Genotype-Stratified Mechanistic Trial of Omega-3 Fatty Acids and FADS Variants in Diet-Induced InflammationR01AT008621US$781.8k2015–20301 Jun 2026reporter.nih.gov